Genetron Holdings Limited

Genetron Holdings Limitedverified

GTH

Price:

$4.025

Market Cap:

$127.29M

Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic ...[Read more]

Industry

Medical - Diagnostics & Research

IPO Date

2020-06-15

Stock Exchange

NASDAQ

Ticker

GTH

The ROE as of October 2024 (TTM) for Genetron Holdings Limited (GTH) is -36.51%

According to Genetron Holdings Limited’s latest financial reports and current stock price. The company's current ROE is -36.51%. This represents a change of 300.00% compared to the average of -9.13% of the last 4 quarters.

Genetron Holdings Limited (GTH) Historical ROE (quarterly & annually)

How has GTH ROE performed in the past?

The mean historical ROE of Genetron Holdings Limited over the last ten years is -13.42%. The current -36.51% ROE has changed 172.04% with respect to the historical average. Over the past ten years (40 quarters), GTH's ROE was at its highest in in the September 2019 quarter at 17.36%. The ROE was at its lowest in in the June 2020 quarter at -144.82%.

Quarterly (TTM)
Annual

Average

-13.42%

Median

3.19%

Minimum

-161.85%

Maximum

67.61%

Genetron Holdings Limited (GTH) ROE by Quarter and Year

Discovering the peaks and valleys of Genetron Holdings Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 345.08%

Maximum Annual ROE = 67.61%

Minimum Annual Increase = -164.74%

Minimum Annual ROE = -161.85%

Quarterly (TTM)
Annual
YearROEChange
2022-161.85%345.08%
2021-36.36%210.68%
2020-11.70%-164.74%
201918.08%-58.63%
201843.70%-35.36%

Genetron Holdings Limited (GTH) Average ROE

How has GTH ROE performed in the past?

The current ROE of Genetron Holdings Limited (GTH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-69.97%

5-year avg

-29.63%

10-year avg

-13.42%

Genetron Holdings Limited (GTH) ROE vs. Peers

How is GTH’s ROE compared to its peers?

Genetron Holdings Limited’s ROE is greater than Psychemedics Corporation (-69.81%), greater than Sera Prognostics, Inc. (-46.71%), greater than Olink Holding AB (publ) (-7.07%), greater than DarioHealth Corp. (-7.91%), greater than Biodesix, Inc. (-525.32%), greater than Aclaris Therapeutics, Inc. (-39.83%), greater than Castle Biosciences, Inc. (-0.77%), greater than Prenetics Global Limited (-29.80%), less than FONAR Corporation (9.23%), greater than Exagen Inc. (-78.90%), less than Sotera Health Company (9.59%), greater than MDxHealth SA (-1069.08%), greater than Inotiv, Inc. (-43.49%),

Build a custom stock screener for Genetron Holdings Limited (GTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genetron Holdings Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genetron Holdings Limited (GTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genetron Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Genetron Holdings Limited's ROE?

How is the ROE calculated for Genetron Holdings Limited (GTH)?

What is the highest ROE for Genetron Holdings Limited (GTH)?

What is the 3-year average ROE for Genetron Holdings Limited (GTH)?

What is the 5-year average ROE for Genetron Holdings Limited (GTH)?

How does the current ROE for Genetron Holdings Limited (GTH) compare to its historical average?